| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| S-Methyl methanesulfonothioate |
甲基硫代磺酸甲酯 |
2949-92-0 |
詳細
|
| CAY10711 |
CAY10711 |
1666171-29-4 |
詳細
|
| Fenchone |
1,3,3-三甲基-二環(huán)[2.2.1]庚-2-酮 |
1195-79-5 |
詳細
|
| Thalidomide-O-amido-C3-NH2 TFA |
Thalidomide-O-amido-C3-NH2 (TFA) |
2022182-58-5 |
詳細
|
| TC-2216 |
化合物TC-2216 |
646055-67-6 |
詳細
|
| DHODH-IN-16 |
化合物DHODH-IN-16 |
2511248-11-4 |
詳細
|
| Orotirelin |
奧替瑞林 |
62305-86-6 |
詳細
|
| CXCL5 Protein, Human, Recombinant |
CXCL5, HUMAN, 重組蛋白 |
|
詳細
|
| hSMG-1 inhibitor 11j |
嘧啶雜質(zhì)1 |
1402452-15-6 |
詳細
|
| Nortriptyline |
去甲替林 |
72-69-5 |
詳細
|
| XL413 hydrochloride |
XL413 HYDROCHLORIDE |
2062200-97-7 |
詳細
|
| Mosunetuzumab |
莫妥珠單抗 |
1905409-39-3 |
詳細
|
| Glenzocimab |
GLENZOCIMAB (格侖西單抗 ) |
2101829-58-5 |
詳細
|
| Desmethyl Erlotinib hydrochloride |
Desmethyl Erlotinib |
183320-51-6 |
詳細
|
| CD73-IN-3 |
5-[6-甲基-5-[(1S,2R)-2-丙-2-基環(huán)丙基]噠嗪-3-基]-1H-嘧啶-2,4-二酮 |
2375815-63-5 |
詳細
|
| 5-Phospho-D-ribose 1-diphosphate (sodium salt hydrate) |
|
|
詳細
|
| dCBP-1 |
化合物DCBP-1 |
2484739-25-3 |
詳細
|
| Vevorisertib trihydrochloride |
化合物VEVORISERTIB TRIHYDROCHLORIDE |
1416775-08-0 |
詳細
|
| Metoprine |
氯苯氨啶 |
7761-45-7 |
詳細
|
| DIPQUO hydrochloride |
化合物DIPQUO鹽酸鹽 |
|
詳細
|
| 4-Thiouridine |
4-硫代尿苷 |
13957-31-8 |
詳細
|
| 17-trifluoromethylphenyl trinor Prostaglandin F2α |
221246-34-0 |
221246-34-0 |
詳細
|
| Safotibant |
N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methylacetamide |
633698-99-4 |
詳細
|
| Aquacycline |
Oxytetracycline hydrochloride |
423769-22-6 |
詳細
|
| CMX-521 |
化合物 CMX-521 |
2077178-99-3 |
詳細
|
| RU-TRAAK-2 |
化合物RU-TRAAK-2 |
1210538-56-9 |
詳細
|
| VT-105 |
VT-105 |
2417718-38-6 |
詳細
|
| Cabozantinib hydrochloride |
鹽酸卡博替尼 |
1817759-42-4 |
詳細
|
| QN523 |
化合物QN523 |
878581-60-3 |
詳細
|
| Capecitabine-2',3'-cyclic Carbonate |
卡培他濱 USP雜質(zhì)C |
921769-65-5 |
詳細
|
| DCBA |
DEET ω-Carboxylic Acid |
72236-23-8 |
詳細
|
| Rhapontigenin 3'-O-glucoside |
丹葉大黃素-3'-O-葡萄糖苷 |
94356-22-6 |
詳細
|
| WAY-647802 |
1-(4-(6-硝基吡啶-3-基)哌嗪-1-基)乙烷-1-酮 |
852225-20-8 |
詳細
|
| WWL123 |
WWL123 |
1338575-41-9 |
詳細
|
| Alfuzosin |
阿夫唑嗪 |
81403-80-7 |
詳細
|
| Vancomycin |
萬古霉素 |
1404-90-6 |
詳細
|
| L-Citronellol |
B-香茅醇 |
7540-51-4 |
詳細
|
| Ifebemtinib FA |
IFEBEMTINIB 甲酸鹽 |
|
詳細
|
| TAT-NSF700 Fusion Peptide acetate |
|
|
詳細
|
| XU1 |
苯并[C][1,8]萘啶-6(5H)-酮 |
53439-81-9 |
詳細
|
| NITD-609 Enantiomer |
NITD-609 對映體 |
1193314-24-7 |
詳細
|
| Fura-2 (sodium salt) |
|
|
詳細
|
| WAY-326766 |
WAY-326766 |
853138-67-7 |
詳細
|
| Naroparcil |
那羅帕西 |
120819-70-7 |
詳細
|
| Cecropin P1, porcine acetate |
化合物CECROPIN P1, PORCINE ACETATE |
|
詳細
|
| IKarisoside A |
寶藿苷II |
55395-07-8 |
詳細
|
| Segetalin B |
王不留行環(huán)肽B |
164991-89-3 |
詳細
|
| EEF1A1 (387-394) (Multiple species) (TFA) |
EEF1A1 (387-394) (MULTIPLE SPECIES) 三氟乙酸 |
|
詳細
|
| HFY-4A HCL (2094810-82-7 Free base) |
|
|
詳細
|
| Bisdionin C |
已酮可可堿雜質(zhì)11 |
74857-22-0 |
詳細
|
| 5-Hydroxydecanoic acid |
5-羥基癸酸鈉鹽 |
624-00-0 |
詳細
|
| RBN-3143 |
PARP14抑制劑 |
2360853-16-1 |
詳細
|
| 6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile |
化合物T64393 |
1314134-92-3 |
詳細
|
| KB-5492 FA |
KB-5492 甲酸鹽 |
|
詳細
|
| 1-O-Hexadecyl-sn-glycerol |
鮫肝醇 |
506-03-6 |
詳細
|
| 9-OxoOTrE |
9-OxoOTrE |
125559-74-2 |
詳細
|
| Relamorelin |
Relamorelin |
661472-41-9 |
詳細
|
| Fmoc-Cys(STmp)-OH |
FMOC-CYS(STMP)-OH(非動物源) |
1403834-74-1 |
詳細
|
| 4-Chloro-3-nitrobenzoic acid |
4-氯-3-硝基苯甲酸 |
96-99-1 |
詳細
|
| Z-D-Arg-Gly-Arg-pNA . 2 HCl |
Z-D-ARG-GLY-ARG-PNA二鹽酸鹽 |
113711-77-6 |
詳細
|
| Cycloleucine |
環(huán)亮氨酸 |
52-52-8 |
詳細
|
| JNJ-10181457 (hydrochloride) |
JNJ 10181457 dihydrochloride |
544707-20-2 |
詳細
|
| (E/Z)-GO289 |
GO 289) |
694522-87-7 |
詳細
|
| Patritumab |
帕曲妥單抗 |
1262787-83-6 |
詳細
|
| SNC 80 |
(+)-4-[(ΑR)-Α-((2S,5R)-4-烯丙基-2,5-二甲基-1-哌嗪基)-3-甲氧基芐基]-N,N-二乙基苯酰胺 |
156727-74-1 |
詳細
|
| T-0156 |
化合物 T23411 |
324572-92-1 |
詳細
|
| N-Acetyl-D-cysteine |
N-乙?；?D-半胱氨酸 |
26117-28-2 |
詳細
|
| UK 227786 |
化合物 UK 227786 |
150452-21-4 |
詳細
|
| HRG/HPRG Protein, Human, Recombinant (His) |
HRG/HPRG, HUMAN, 重組蛋白 (HIS) |
|
詳細
|
| FIIN-1 |
FIIN-1 |
1256152-35-8 |
詳細
|
| Xanomeline tartrate |
酒石酸沙諾美林 |
152854-19-8 |
詳細
|
| tricoumaroyl spermidine |
tricoumaroyl spermidine |
131086-78-7 |
詳細
|
| AY 77 |
AY77 |
1835734-92-3 |
詳細
|
| DDO-5936 |
化合物DDO-5936 |
2355377-13-6 |
詳細
|
| Isothiuronium |
2-undec-10-enylisothiouronium iodide |
22584-04-9 |
詳細
|
| UNC9975 |
化合物 T29064 |
1354030-19-5 |
詳細
|
| Chromeceptin |
2-氨基-7-(二甲基氨基)-4-(3-(三氟甲基)苯基)-4H-苯并吡喃-3-甲腈 |
331859-86-0 |
詳細
|
| MRTX0902 |
MRTX0902 |
2654743-22-1 |
詳細
|
| hCAII-IN-9 |
化合物HCAII-IN-9 |
2878477-18-8 |
詳細
|
| EGF Protein, Human, Recombinant |
URG|||EPIDERMAL GROWTH FACTOR|||表皮生長因子|||HOMG4 |
|
詳細
|
| PF-03049423 |
化合物 PF-03049423 |
954138-07-9 |
詳細
|
| (±)10(11)-EDP Ethanolamide |
(±)10(11)-EDP ETHANOLAMIDE |
2123484-71-7 |
詳細
|
| FFN200 dihydrochloride |
FFN 200 DIHYDROCHLORIDE |
2080306-27-8 |
詳細
|
| Safingol hydrochloride |
沙芬戈鹽酸鹽 |
139755-79-6 |
詳細
|
| Aβ42-IN-2 |
化合物AΒ42-IN-2 |
1914989-80-2 |
詳細
|
| Cell-cell interaction 1 |
Azepino[2,1-b]quinazoline-3-carboxamide, 6,7,8,9,10,12-hexahydro-N-[1-(1-methylethyl)-4-piperidinyl]-12-oxo- |
918328-92-4 |
詳細
|
| Dimethyl-W84 (dibromide) |
DIMETHYL-W84 DIBROMIDE |
402475-33-6 |
詳細
|
| PCO 400 |
(-)-(3S,4R)-3,4-二氫-3-羥基-2,2-甲基-4-(3氧-1-環(huán)戊基-2-氧)-2H-1-苯基吡喃-6-碳腈 |
121055-10-5 |
詳細
|
| 8-iso Prostaglandin F2β |
8-ISO PROSTAGLANDIN F2BETA |
177020-26-7 |
詳細
|
| INF 195 |
|
1211379-56-4 |
詳細
|
| TNF-α-IN-9 |
化合物TNF-Α-IN-9 |
2054199-25-4 |
詳細
|
| RS 56812 |
化合物 RS 56812 |
143137-37-5 |
詳細
|
| Zopolrestat |
唑泊司他 |
110703-94-1 |
詳細
|
| Fosphenytoin |
磷苯妥英 |
93390-81-9 |
詳細
|
| Mtb-IN-2 |
MTB抑制劑2 |
2861190-30-7 |
詳細
|
| (±)5(6)-EET |
(±)-順式-5,6-環(huán)氧-8(Z),11(Z),14(Z)-二十碳三烯酸 |
87173-80-6 |
詳細
|
| DSPE-NHS |
DSPE-NHS |
1383932-86-2 |
詳細
|
| Inhibin alpha chain/INHA Protein, Bovine, Recombinant (His & SUMO) |
INHIBIN ALPHA CHAIN/INHA, BOVINE, 重組蛋白 (HIS & SUMO) |
|
詳細
|
| PAM Protein, Human, Recombinant (His) |
PAM, HUMAN, 重組蛋白 (HIS) |
|
詳細
|